Physician profile
Edmond F Ritter
NPI 1982793378
$44,983.00
in general payments reported to CMS, 2019-2025
33 companies · $9,405 in 2025
The $9,405 reported for 2025 was more than what 94% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,462 · 2020: $9,084 · 2021: $1,908 · 2022: $2,696 · 2023: $7,678 · 2024: $11K · 2025: $9,405.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $16K · Consulting Fee: $8,830 · Travel and Lodging: $3,455.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $15,548.84 |
| Consulting Fee | $8,830.00 |
| Travel and Lodging | $3,454.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avita Medical Americas, LLC | $10,576.49 | 2023-2025 | Recell, Cohealyx, Permeaderm |
| Polarityte, INC. | $9,936.91 | 2019-2021 | |
| Axogen | $4,201.67 | 2019-2025 | Avance Nerve Graft, Axoguard Nerve Protector, Axoguard Nerve Cap |
| Access Pro Medical, LLC | $2,718.41 | 2022-2025 | Matriderm, Matriderm |
| Abbvie INC. | $2,256.19 | 2023-2025 | Strattice Reconstructive Tissue Matrix Bps |
| Stryker Corporation | $1,903.78 | 2019-2025 | Na, Vsp System, Vsp Cranial, Delta |
| Kerecis Limited | $1,730.65 | 2024-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Graftguide |
| Integra Lifesciences Corporation | $1,564.05 | 2020-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Musculoskeletal Transplant Foundation INC. | $1,207.04 | 2024-2025 | |
| Depuy Synthes Sales INC. | $1,125.78 | 2020-2025 | Trumatch |
| Smith+Nephew, INC. | $1,077.84 | 2019-2025 | Grafix Pl |
| Dilon Technologies, INC. | $1,037.50 | 2025 | Hemoblast Bellows |
| W. L. Gore & Associates, INC. | $823.49 | 2024-2025 | Gore Excluder Thoracoabdominal Branch Endoprosthesis, Gore Enform Preperitoneal Biomaterial, Gore Tag Thoracic Branch Endoprosthesis |
| Kci USA, INC. | $800.00 | 2019 | |
| Tela Bio, INC. | $672.82 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $420.86 | 2021-2022 | |
| Polynovo North America LLC | $328.30 | 2023-2025 | Novosorb Btm |
| Solventum Corporation | $326.02 | 2024-2025 | V.A.C.Ulta, V.A.C. Dermatac, Prevena |
| Zimmer Biomet Holdings, INC. | $323.81 | 2019-2025 | Traumaone, Omnimax |
| Sanara Medtech INC. | $317.56 | 2022 | |
| Ethicon US, LLC | $275.74 | 2020-2025 | Ethicon, Vistaseal |
| Medtronic, INC. | $271.17 | 2024-2025 | Ligasure, Progrip |
| Bioventus LLC | $242.29 | 2022 | |
| Davol INC. | $201.63 | 2025 | Phasix Mesh |
| Biocomposites INC | $147.79 | 2025 | Stimulan |
| Bard Peripheral Vascular, INC. | $126.61 | 2021 | |
| Organogenesis INC. | $123.01 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $92.17 | 2024 | Iovera |
| Lemaitre Vascular, INC. | $74.80 | 2019 | |
| Lifenet Health | $29.17 | 2025 | Theragenesis Wound Matrix |
| Paratek Pharmaceuticals, INC. | $19.86 | 2022 | |
| Medtronic USA, INC. | $15.86 | 2020 | |
| Coopersurgical, INC. | $13.73 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edmond Ritter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.